Summary
The binding of lipophilic drugs to albumin and erythrocytes and its importance for the uptake of the drugs into the isolated rat liver were investigated. Promazine and chlorpromazine were taken as lipophilic drugs, which were compared in some experiments with 3,3′-dimethyl-4,4′-diacetyldiphenylbisguanylhydrazone (BG 60), a much more hydrophilic drug.
The perfusion medium contained 2% albumin, about 30% bovine erythrocytes and the drug in a concentration of 10−4 M respectively 1.3×l0−4 M in Krebs-Henseleit-solution. In this solution promazine was bound to erythrocytes (69%) and to albumin (20%) whereas the buffer solution contained 11%; 77% of chlorpromazine were bound to erythrocytes, 19% to albumin, whereas the buffer solution contained 4% (Table 1). The distribution of chlorpromazine in the perfusion medium did not depend on the time of incubation (Fig. 1). Increasing the albumin concentration of the perfusion medium caused a rise of the chlorpromazine fraction bound to albumin and a decrease of the fraction bound to the erythrocytes and the fraction of the free, unbound substance (Table 3).
The distribution of BG 60 in the perfusion medium markedly depended on the time of incubation. Without incubation 7.5% of BG 60 were bound to erythrocytes, 63% were bound after an incubation time of 2 h (Fig. 1).
When suramine was added to the perfusion medium the fraction of promazine bound to albumin increased and the fraction bound to erythrocytes decreased, whereas the fraction of the free substance in the aqueous phase was not significantly changed. In a perfusion medium lacking erythrocytes the fraction of free promazine was considerably higher (Table 1).
After the perfusion medium had passed the liver one times, the total chlorpromazine (the fractions of the free and the bound substance) of the first part of the perfusion medium (50 ml) was extracted by the liver (Fig.2). This led to the suggestion that the binding of the phenothiazine derivatives to the membranes of erythrocytes was reversible.
In the experiments with BG 60 no fraction of the perfusate of the liver was found, which did not contain BG 60. Beyond that the uptake of BG 60 into the liver depended on the time of incubation of the perfusion medium (Fig. 2).
Chlorpromazine was taken up more rapidly than promazine into the recirculating perfused liver (Fig. 3). By suramine the uptake of promazine into the liver was enlarged. KCN did not markedly change the uptake of promazine into the liver (Table 4). If there were no erythrocytes in the perfusion medium the initial uptake of promazine into the liver was increased (Fig.4).
There seems to be no difference in the biotransformation of promazine and chlorpromazine as the examination of the perfusate and liver homogenate by thin layer chromatography pointed out. In the experiments with a perfusion medium lacking erythrocytes promazine was much less metabolized (Table 5).
The binding of lipophilic substances to erythrocytes may be of similar pharmacokinetic importance as the binding of substances to plasma proteins, as the experiments demonstrated.
Similar content being viewed by others
Literatur
Bird, A. E., Marshall, A. C.: Correlation of serum binding of penicillins with partition coefficients. Biochem. Pharmacol.16, 2275 (1967).
Brodie, B. B., Hogben, C. A. M.: Some physico-chemical factors in drug action. J. Pharm. Pharmacol.9, 345 (1957).
Cordelli, A., Ferrari, M., Savonitto, E.: Metabolism of chlorpromazine and related psychotropic drugs in the isolated perfused rat liver. Arch. int. Pharmacodyn.180, 121 (1969).
Desgrez, P., DeTraverse, P. M.: Transport function of plasma proteins. Amsterdam-London-New York: Elsevier Publ. Comp. 1966.
Dettli, L.: Der Konzentrationsbegriff in der Chemotherapie mit Sulfanilamiden. Arzneimittel-Forsch.11, 861 (1961).
Dost, F. H.: Grundlagen der Pharmakokinetik, 2. Aufl. Stuttgart: Thieme 1968.
Ehmer, A., Jahr, K., Kuschinsky, G., Lüllmann, H., Mutschler, E., Wollert, U.: Über die Herzwirksamkeit einfacher Bisguanylhydrazone. Arzneimittel-Forsch.14, 1273 (1964).
Franz, J. W., Jähnchen, E., Krieglstein, J.: Der Einfluß verschiedener Pharmaka auf das Bindungsvermögen einer Albuminlösung für Promazin und Chlorpromazin. Naunyn-Schmiedebergs Arch. Pharmak.264, 462 (1969).
Glasser, H., Krieglstein, J.: Die Eiweißbindung einiger Psychopharmaka mit tricyclischem Ringsystem in Abhängigkeit von ihrer chemischen Konstitution. Naunyn-Sehmiedebergs Arch. Pharmak.265, 321 (1970).
Goldstein, A.: The interactions of drugs and plasma proteins. Pharmacol. Rev.1, 120 (1949).
Greim, H.: Therapeutische Möglichkeiten durch die Induzierbarkeit arzneimittelabbauender Enzyme. Dtsch. med. Wschr.95, 2196 (1970).
Hansch, C., Kiehs, K., Lawrence, G. L.: The role of substituents in the hydrophobic bonding of phenols by serum and mitochondrial proteins. J. Amer. chem. Soc.87, 5770 (1965).
Hems, R., Ross, B. D., Berry, M. N., Krebs, H. A.: Gluconeogenesis in the perfused rat liver. Biochem. J.101, 284 (1966).
Hofmann, P., Wollert, U.: Eine Methode zum quantitativen Nachweis von Guanylhydrazonen und deren Bestimmung in tierischem Material. Arzneimittel-Forsch.19, 138 (1969).
Jähnchen, E.: Bestimmung der Eiweißbindung von Pharmaka in bikarbonatgepufiferten Lösungen. Experientia (Basel)20, 681 (1970).
—, Krieglstein, J.: Die Aufnahme von Promazin, Chlorpromazin und deren Desmethylmetaboliten in das isoliert perfundierte Rattenhirn. Naunyn-Schmiedebergs Arch. Pharmak.268, 300 (1971).
— —, Kunkel, F., Samuelis, W. J.: Der hydrophobe Charakter von Phenothiazinderivaten als entscheidende Größe für deren initiale Aufnahme in die isoliert perfundierte Rattenleber. Naunyn-Schmiedebergs Arch. Pharmak.266, 363 (1970).
Krieglstein, J.: Zur Plasmaproteinbindung von Arzneimitteln. Klin. Wschr.47, 1125 (1969a).
—: Über die Wechselwirkung der Plasma- und Gewebsproteinbindung von Promazin, untersucht an der isoliert perfundierten Rattenleber. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path.262, 474 (1969b).
—, Kuschinsky, G.: Quantitative Bestimmung der Eiweißbindung von Pharmaka durch Gelfiltration. Arzneimittel-Forsch.18, 287 (1968).
— —: Über die Wechselwirkung von Phenothiazinderivaten mit Rinderserumalbumin. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path.262, 1 (1969).
Kurz, H.: Lipid solubility as an important factor for the penetration of drugs into the liver. Biochem. Pharmacol.8, 20 (1961).
—: Die Permeation von Giften in die Leber. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.247, 164 (1964).
—: Die Bedeutung der Lipoidlöslichkeit in der Pharmakologie. Präparat. Pharmaz.1, 1 (1970).
Kwant, W. O., Seeman, P.: The membrane concentration of a local anesthetic (chlorpromazine). Biochim. biophys. Acta (Amst.).183, 530 (1969).
Meyer, M. C., Gutman, D. E.: The binding of drugs by plasma proteins. J. pharm. Sci.57, 895 (1968).
Miller, L. L., Bly, C. G., Watson, M. L., Bale, W. F.: The dominant role of the liver in plasma protein synthesis. J. exp. Med.94, 431 (1951).
Pulver, R.: Die Verteilung von Medikamenten zwischen Blutkörperchen und Plasma. Arzneimittel-Forsch.15, 1363 (1965).
Raaflaub, J.: Über die Beziehungen zwischen der Lipidlöslichkeit von Pharmaka und ihrem pharmakokinetischen Verhalten. Experientia (Basel)26, 457 (1970).
Schanker, L. S.: Passage of drugs across body membranes. Pharmacol. Rev.14, 501 (1962).
Schanker, L. S., Nafpliotis, P. A., Johnson, J. M.,: Passage of organic bases into human red cells. J. Pharmacol. exp. Ther.133, 325 (1961).
Scheler, W.: Grundlagen der allgemeinen Pharmakologie, 1. Aufl. Jena: Fischer 1969.
Schimassek, H.: Perfusion of isolated rat liver with a semisynthetic medium and control of liver function. Life Sci.11, 629 (1962).
—: In: Stoffwechsel der isoliert perfundierten Leber (Hrsg. W. Staib und R. Scholz). Berlin-Heidelberg-New York: Springer 1968.
Scholtan, W.: Die hydrophobe Bindung der Pharmaka an Humanalbumin und Ribonucleinsäure. Arzneimittel-Forsch.18, 505 (1968).
Staib, W., Scholz, R.: Stoffwechsel der isoliert perfundierten Leber. Berlin-Heidelberg-New York: Springer 1968.
Walkenstein, S. S., Seifter, J.: Fate, distribution and excretion of S35-promazine. J. Pharmacol. exp. Ther.125, 283 (1959).
Wechsler, M. B., Roizin, L.: Tissue levels of chlorpromazine in experimental animals. J. ment. Sci.106, 1501 (1960).
Wunderly, C., Wuhrmann, F.: Über die Wechselbeziehungen zwischen den Plasmaproteinen und dem Gewebe. Schweiz, med. Wschr.45, 1102 (1951).
Author information
Authors and Affiliations
Additional information
Die Arbeit wurde mit Unterstützung der Deutsehen Forsehungsgemeinschaft durchgefiihrt. Herrn Dr. J. Miehaelis von Institut für Medizinische Statistik der Universität Mainz danken wir für die kritisehe Beratung und Unterstützung bei der statistischen Auswertung, Fraulein W. Kraus und Fraulein H. Seufert für sorgfältige technische Mitarbeit bei den Versuehen.
Rights and permissions
About this article
Cite this article
Jähnchen, E., Krieglstein, J., Kunkel, F. et al. Die Bedeutung der Bindung von Pharmaka an Albumin und Erythrocyten eines Perfusionsmediums der isolierten Rattenleber. Naunyn-Schmiedebergs Arch. Pharmak. 269, 67–84 (1971). https://doi.org/10.1007/BF01422017
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01422017